DXCM Financial Facts
Total revenue: 29.6MBasic and diluted net loss per share: -0.16
See Full Income Statement
Inventory: 7.5M
Accounts payable and accrued liabilities: 7.5M
See Full Balance Sheet
Earnings History for DexCom, Inc. (DXCM)
|
Expand Research on DXCM
| Next EPS Date | 8/5/13 *Est. | EPS Growth Rate | +23.8% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +3.1% | Revenue Growth Rate | +47.3% *Last Qtr. |
| Average % Move 1-Wk after EPS | +5.3% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/1/13  |
 |
Q113 | -$0.16 | -$0.17 | +$0.01 | $29.6M | $28.33M | N/A / N/A | N/A | +19.9% | Details |
| 2/21/13 |
|
Q412 | -$0.12 | -$0.16 | +$0.04 | $33.3M | $31.09M | N/A / N/A | N/A | +43.5% | Details |
| 11/1/12 |
|
Q312 | -$0.25 | -$0.22 | -$0.03 | $23.1M | $23.14M | N/A / N/A | N/A | +55.1% | Details |
| 8/6/12 |
|
Q212 | -$0.21 | -$0.20 | -$0.01 | $23.5M | $22.24M | N/A / N/A | N/A | +70.2% | Details |
| 5/2/12 |
Q112 | -$0.21 | -$0.19 | -$0.02 | $20.1M | $19.88M | N/A / N/A | N/A | +100.5% | Details | |
| 2/23/12 |
|
Q411 | -$0.18 | -$0.17 | -$0.01 | $22.4M | $21.63M | N/A / N/A | N/A | 0% | Details |
| 11/2/11 |
|
Q311 | -$0.20 | -$0.16 | -$0.04 | $18.3M | $19.05M | N/A / N/A | N/A | +106.8% | Details |
| 8/3/11 |
|
Q211 | -$0.11 | -$0.12 | +$0.01 | $21.4M | $20.83M | N/A / N/A | N/A | +51.4% | Details |
